Letter to the Editor August 1, 2002

A Case Report of Methylphenidate-Induced Dyskinesia

Prim Care Companion J Clin Psychiatry 2002;4(4):158-159

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Movement disorders have long been associated with awide variety of medications and illicit drugs. Dopaminergicagents are well-known precipitants of various dyskinesias, includingchorea, choreoathetosis, dystonia, and ballism. For example,levodopa-induced dyskinesias are a relatively commonside effect of the treatment of Parkinson’s disease, with up to45% of patients affected after 5 years of such treatment.1